1. Hester Biosciences
stock logo

100% Hold

Hester Biosciences Share Price

HESTERBIO

₹2,714.70+₹268.85 (10.99%) TodayLast updated on 24 Jul, 2024 | 15:49 IST
₹2,445.85₹2,738.45
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹2,081 Crs

Open

₹2,445.85

Close

₹2,445.85

Circuit range

₹2,935.00 - ₹1,956.70

Day range

₹2,445.85 - ₹2,738.45

Year range

₹1,292.85 - ₹2,880.45

Volume

24,117

Avg. traded

₹2,638.63

Revenue (12m)

₹305 Crs

Hester BiosciencesHester Biosciences Limited is an India-based animal healthcare company. The Company is engaged in providing vaccines, health products and diagnostic laboratory services. The Company operates through four segments: Poultry Healthcare, Animal Healthcare, Petcare, and Others. The Animal Healthcare vaccines include Goat Pox Vaccine, Live Brucella, PPR Vaccine - Nigerian 75/1, and PPR Vaccine - Sungri/96. Its Poultry Healthcare products include Gumboro I, Gumboro I +, Inactivated Chick ND, Inactivated Coryza, Inactivated Coryza+, Inactivated EDS, Inactivated FC3, Inactivated FC4, Inactivated IB, Inactivated IB+, Inactivated IB-H52, Inactivated IBD, Inactivated IBD ND, Inactivated IBD ND EDS, Inactivated ND IB, Inactivated Pullet ND, Live B1, Live B1 M48, Live FP, Live H120, Live Las, Live Las Mas, Live M48, Live R2B, Live S-One, MD-Bivalent HVT+SB1, MD-HVT (FD), and Thermostable ND. Its Petcare products include Cefshot Tazo Injection, Hestacef CV, Hestacef DS, Hestaflam Tablet and Hestaliv.

Hester Biosciences Key indicators

arrow

52 week high

₹2,880.45

52 week low

₹1,292.85

P/E ratio

98.27

P/B ratio

8

ROE

11.53%

ROCE

11.91%

Dividend yield

0.23%

Debt/Equity ratio

0.56

EPS

38.02

Learn more

Investment checklist: (4/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Hold

arrow

Buy

0%

Hold

100%

Sell

0%

This analysis is based on the reviews of 1 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

23.53%

Net profit margin

12.64%

ROE

11.53%

ROA

6.67%

ROCE

11.91%

Learn more

Hester Biosciences Shareholder returns

arrow

1 day

-5.02%

1 week

-11.53%

1 month

-1.93%

3 months

+47.46%

1 year

+39.51%

3 years

+1.42%

5 years

+45.69%

Hester Biosciences Share Price history

arrow
DayOpenCloseDay’s change
Tue, Jul 23 2024
₹2,613.75
₹2,445.85
-5.02%
Mon, Jul 22 2024
₹2,550.00
₹2,575.15
+0.18%
Fri, Jul 19 2024
₹2,745.80
₹2,570.55
-6.38%
Thu, Jul 18 2024
₹2,870.00
₹2,745.80
-4.17%
Tue, Jul 16 2024
₹2,792.15
₹2,865.15
+3.64%
Mon, Jul 15 2024
₹2,693.05
₹2,764.50
+2.98%
Fri, Jul 12 2024
₹2,661.65
₹2,684.50
+1.79%
Thu, Jul 11 2024
₹2,693.10
₹2,637.20
-1.34%

Shareholding info

arrow

Promoters (53.73%)

Mutual Funds (0%)

Retail and other (45.74%)

Foreign institutions-FII (0.52%)

Other domestic institutions (0%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹8/share

    Ex date 13 Sep 2023

    expand tab
  • Dividend • ₹10/share

    Ex date 11 Aug 2022

    expand tab
  • Dividend • ₹6/share

    Ex date

    expand tab

Learn more

Frequently asked questions